Stay updated with breaking news from Nasdaq Bmea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report)’s share price shot up 2.6% during mid-day trading on Wednesday . The company traded as high as $15.27 and last traded at $15.09. 9,242 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 675,203 shares. The stock had previously closed […]
Biomea Fusion (NASDAQ:BMEA – Get Free Report) and Agile Therapeutics (NASDAQ:AGRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Biomea Fusion has a […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 7,490,000 shares, a decrease of 9.5% from the July 15th total of 8,280,000 shares. Based on an average daily volume of 830,700 shares, […]
Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month target price […]
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]